SELLAS Life Sciences Group Inc (NASDAQ: SLS) kicked off on Friday, up 10.96% from the previous trading day, before settling in for the closing price of $1.46. Over the past 52 weeks, SLS has traded in a range of $0.77-$2.48.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 45.94%. While this was happening, its average annual earnings per share was recorded 47.00%. With a float of $142.00 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 0.31%, while institutional ownership is 23.23%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.08 earnings per share (EPS), higher than consensus estimate (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.20% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Take a look at SELLAS Life Sciences Group Inc’s (SLS) current performance indicators. Last quarter, stock had a quick ratio of 8.28. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
The latest stats from [SELLAS Life Sciences Group Inc, SLS] show that its last 5-days average volume of 3.08 million was superior to 2.81 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 47.44%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 21.10%, which indicates a significant decrease from 88.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1155 in the past 14 days, which was lower than the 0.1228 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7449, while its 200-day Moving Average is $1.6068. Now, the first resistance to watch is $1.6850. This is followed by the second major resistance level at $1.7500. The third major resistance level sits at $1.8600. If the price goes on to break the first support level at $1.5100, it is likely to go to the next support level at $1.4000. The third support level lies at $1.3350 if the price breaches the second support level.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
The company with the Market Capitalisation of 230.76 million has total of 142,442K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -30,880 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,790 K.
